secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001213900-25-051191
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar Therapeutics announces 1-for-15 reverse stock split effective June 8
---------------------------------------------------------------------------

- Board approved 1-for-15 reverse stock split effective June 8, 2025 at 11:59 p.m. ET.
- Stockholders authorized reverse split ratio up to 1:40 at May 23 annual meeting; Board selected 1:15.
- Split-adjusted trading begins June 9 under symbol NKTR with new CUSIP 640268306.
- No fractional shares issued; rounding up for DTC participants, down for stock awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390025051191/0001213900-25-051191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390025051191/ea0244011-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-051191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer